John M. Hoffmann

Array ( [id] => 11575774 [patent_doc_number] => 09631020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Anti-c-Met antibody having HGF activity and use thereof' [patent_app_type] => utility [patent_app_number] => 14/123533 [patent_app_country] => US [patent_app_date] => 2012-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 13038 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8489085 [patent_doc_number] => 20120288493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-15 [patent_title] => 'METHOD OF INHIBITNG COMPLEMENT ACTIVATION WITH HUMAN ANTI-FACTOR C3 ANTIBODIES AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/475150 [patent_app_country] => US [patent_app_date] => 2012-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 27356 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10063907 [patent_doc_number] => 09102738 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-11 [patent_title] => 'Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)' [patent_app_type] => utility [patent_app_number] => 13/468624 [patent_app_country] => US [patent_app_date] => 2012-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 34 [patent_no_of_words] => 35516 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8707536 [patent_doc_number] => 20130064825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'METHODS OF TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/469032 [patent_app_country] => US [patent_app_date] => 2012-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 155 [patent_figures_cnt] => 155 [patent_no_of_words] => 84579 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13469032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9074578 [patent_doc_number] => 08552157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'c-Kit antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/462853 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 11322 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13462853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8358639 [patent_doc_number] => 20120213797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-23 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/463751 [patent_app_country] => US [patent_app_date] => 2012-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 153 [patent_figures_cnt] => 153 [patent_no_of_words] => 73054 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13463751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9608436 [patent_doc_number] => 08785603 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Antibodies to 25-hydroxyvitamin D2 and D3 and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/458847 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23562 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12009720 [patent_doc_number] => 09803026 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-31 [patent_title] => 'Anti-human receptor-type protein tyrosine phosphatase sigma antibody' [patent_app_type] => utility [patent_app_number] => 14/113904 [patent_app_country] => US [patent_app_date] => 2012-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 25606 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8346840 [patent_doc_number] => 20120207764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES TO PROTEIN TYROSINE KINASE 7 (PTK7) AND METHODS FOR USING ANTI-PTK7 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/442499 [patent_app_country] => US [patent_app_date] => 2012-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 35512 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10136016 [patent_doc_number] => 09169330 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Hybridoma producing anti-methylated DNA antibody and utilization of same' [patent_app_type] => utility [patent_app_number] => 13/430295 [patent_app_country] => US [patent_app_date] => 2012-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9544 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618339 [patent_doc_number] => 20130023651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'PEPTIDES FOR TREATMENT AND DIAGNOSIS OF BONE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/427296 [patent_app_country] => US [patent_app_date] => 2012-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 17718 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13427296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8733932 [patent_doc_number] => 20130079501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/422904 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 152 [patent_figures_cnt] => 152 [patent_no_of_words] => 73125 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8745548 [patent_doc_number] => 20130085265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'ANTIGEN BINDING PROTEINS TO PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9 (PCSK9)' [patent_app_type] => utility [patent_app_number] => 13/422887 [patent_app_country] => US [patent_app_date] => 2012-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 153 [patent_figures_cnt] => 153 [patent_no_of_words] => 73138 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13422887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13253471 [patent_doc_number] => 10139420 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-11-27 [patent_title] => Methods for treating vaso-occlusive crisis using non-modified annexin V [patent_app_type] => utility [patent_app_number] => 14/003919 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 17672 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14003919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9250521 [patent_doc_number] => 08614300 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-24 [patent_title] => 'Nucleic acids encoding a mut-T domain-containing polypeptide' [patent_app_type] => utility [patent_app_number] => 13/416854 [patent_app_country] => US [patent_app_date] => 2012-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 6 [patent_no_of_words] => 19268 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13416854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199277 [patent_doc_number] => 20120122762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => '186 Human Secreted Proteins' [patent_app_type] => utility [patent_app_number] => 13/359199 [patent_app_country] => US [patent_app_date] => 2012-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 231724 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122762.pdf [firstpage_image] =>[orig_patent_app_number] => 13359199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8335076 [patent_doc_number] => 20120201756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'PLASMA KALLIKREIN BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/345170 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 89685 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345170 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8171204 [patent_doc_number] => 20120107231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'METALLOPROTEINASE BINDING PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/335185 [patent_app_country] => US [patent_app_date] => 2011-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 57436 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20120107231.pdf [firstpage_image] =>[orig_patent_app_number] => 13335185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8185243 [patent_doc_number] => 20120115172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'PTEN/AKT METHODS AND COMPOSITIONS RELATING TO BMP' [patent_app_type] => utility [patent_app_number] => 13/327014 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 23559 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115172.pdf [firstpage_image] =>[orig_patent_app_number] => 13327014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8312605 [patent_doc_number] => 20120189626 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-26 [patent_title] => 'TREATMENT OF COMPLEMENT-ASSOCIATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/327523 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 77 [patent_figures_cnt] => 77 [patent_no_of_words] => 45515 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13327523 [rel_patent_id] =>[rel_patent_doc_number] =>)